C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61P 35/00 (2006.01) C07K 16/18 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2676436
The present invention relates to vitro diagnosis methods of prostate cancer from a test biological sample, comprising measuring the expression level of KIAA0153 in said test biological sample,as well as to methods for screening compounds inhibiting KIAA0153 gene expression or biological activity and uses of such KIAA0153 inhibiting compounds.
La présente invention porte sur des procédés de diagnostic in vitro du cancer de la prostate à partir d'un échantillon biologique test, comprenant la mesure du niveau d'expression de KIAA0153 dans ledit échantillon biologique test, ainsi que sur des procédés de criblage de composés inhibant l'expression génique ou l'activité biologique de KIAA0153 et sur des utilisations de tels composés inhibant KIAA0153.
Abecassis Joseph
Klocker Helmut
Schalken Jack A.
Wasylyk Bohdan
Zambrano Alberto
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Centre National de La Recherche Scientifique (cnrs)
Centre Paul Strauss
Universite Louis Pasteur
LandOfFree
Diagnosis of prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis of prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of prostate cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2036631